This finding has practical implications
These drugsoften prescribed under brand names like Ozempic, Wegovy, Saxenda, and Zepboundare well-known for regulating blood sugar and supporting significant weight loss
[1] It is characterised by a combination of symptoms including irregular menstrual cycles, elevated androgen levels (male hormones), and polycystic ovaries visible on ultrasound
La tirzepatida, un agonista dual GIP/GLP-1, ha demostrado reducciones an mayores (15-21% en el estudio SURMOUNT-1)
The FDA/SAHPRAdoes not allow product claims on dietary supplement products
Melisa Dirchwolf: Review and Editing, Javiera Carreo: Review and Editing, Brbara Samith: Review and Editing, Cynthia Valrio: Review and Editing, Rodrigo Oliveira Moreira: Review and Editing, Mnica Acevedo: Review and Editing, Javier Brahm: Review and Editing, Nelia Hernndez: Review and Editing, Adrian Gadano: Review and Editing, Claudia P